Fleming William Kevin's Form 4 filing
Humana IncHUM · filed May 2, 2022
- Accession no.
- 0001062993-22-011163
- Filed
- May 2, 2022
- Trade date
- Apr 28, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market sales total $1.44M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Fleming William KevinCIK 0001699801 | Officer (Seg Pres, Pharmacy Sol & CCAO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 28, 2022 | Humana Common | GGiftAcquired | +663 | $0.00 | $0 | 4,094 | Direct | |
| Apr 28, 2022 | Humana Common | SSaleDisposed | −3,210 | $449.68F13 | −$1,443,472.8 | 884 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F13
Price reported is weighted average sales price.
Referenced by the price of 1 transaction in Table I.